GlassScriptPhysician profile
Brett Vassallo
NPI 1386654408
$4,407.01
in general payments reported to CMS, 2019-2025
26 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,468 · 2020: $135 · 2021: $212 · 2022: $1,360 · 2023: $479 · 2024: $543 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,232.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $1,113.41 | 2019-2022 | |
| Momentis Surgical INC. | $1,040.20 | 2022-2023 | Anovo Surgical System |
| Boston Scientific Corporation | $749.99 | 2019-2025 | Solyx Sis System, Advantage System, Bulkamid |
| Axonics, INC. | $319.20 | 2022-2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $185.42 | 2019-2023 | Veozah |
| Sumitomo Pharma America, INC. | $173.99 | 2023-2025 | Gemtesa |
| Allergan, INC. | $112.89 | 2019-2021 | |
| Applied Medical Resources Corporation | $107.77 | 2024 | Gelpoint V-Path |
| Therapeuticsmd, INC. | $78.27 | 2019-2022 | |
| Abbvie INC. | $75.29 | 2019-2024 | |
| Convatec INC. | $67.16 | 2022-2024 | |
| Urovant Sciences INC | $60.36 | 2022 | |
| Coloplast Corp | $38.64 | 2019 | |
| Duchesnay USA Incorporated | $36.48 | 2019 | |
| Valencia Technologies Corporation | $32.64 | 2025 | Ecoin Device Kit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $25.98 | 2022 | |
| Bluewind Medical | $23.05 | 2024 | Revi |
| Myovant Sciences INC. | $21.75 | 2021 | |
| Femselect INC. | $21.19 | 2025 | Enplace |
| Hologic Sales and Service, LLC | $20.36 | 2024 | Aptima |
| Ethicon US, LLC | $19.97 | 2021 | |
| Medtronic, INC. | $19.66 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.40 | 2025 | Exparel |
| Lsi Solutions INC | $17.35 | 2025 | Fornisee |
| Northgate Technologies, INC. | $15.34 | 2023 | Nti Branded Other (Nti) |
| Coopersurgical, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Vassallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.